Published August 9, 2018 | Version v1
Journal article Open

Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice

  • 1. Laboratory of Molecular Neurobiology, Department of Neuroscience, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156, Milan, Italy
  • 2. Laboratory of Analytical Biochemistry, Department of Environmental Health Sciences, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa 19, 20156, Milan, Italy
  • 3. Neuropathology Unit, Department of Neurology, INSPE- San Raffaele Scientific Institute, Dibit II, Via Olgettina 48, 20132, Milan, Italy
  • 4. Laboratory of Cancer Pharmacology Department of Oncology, Flow Cytometry Unit, IRCCS – Istituto di Ricerche Farmacologiche Mario Negri, via La Masa 19, 20156, Milan, Italy

Description

Background: The major histocompatibility complex I (MHCI) is a key molecule for the interaction of mononucleated cells with CD8+T lymphocytes. We previously showed that MHCI is upregulated in the spinal cord microglia and motor axons of transgenic SOD1G93A mice.

Methods: To assess the role of MHCI in the disease, we examined transgenic SOD1G93A mice crossbred with β2 microglobulin-deficient mice, which express little if any MHCI on the cell surface and are defective for CD8+ T cells.

Results: The lack of MHCI and CD8+ T cells in the sciatic nerve affects the motor axon stability, anticipating the muscle atrophy and the disease onset. In contrast, MHCI depletion in resident microglia and the lack of CD8+ T cell infiltration in the spinal cord protect the cervical motor neurons delaying the paralysis of forelimbs and prolonging the survival of SOD1G93A mice.

Conclusions: We provided straightforward evidence for a dual role of MHCI in the peripheral nervous system (PNS) compared to the CNS, pointing out regional and temporal differences in the clinical responses of ALS mice. These findings offer a possible explanation for the failure of systemic immunomodulatory treatments and suggest new potential strategies to prevent the progression of ALS.

Files

13024_2018_Article_271.pdf

Files (39.5 MB)

Name Size Download all
md5:52bd4bc996dbb35c3451cb47854007c9
23.1 MB Download
md5:5911dcc3091531ee0663002bcb98d4a5
16.5 MB Preview Download
md5:e4f6dc4ab5b374f7c7ff71f7af8b28b3
25.0 kB Download

Additional details

Funding

EURO-MOTOR – European multidisciplinary ALS network identification to cure motor neuron degeneration 259867
European Commission